Navigation Links
Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research
Date:7/7/2009

WASHINGTON, July 7 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, Chairman of the U.S. Catholic Bishops' Committee on Pro-Life Activities, reacted today to final guidelines for human embryonic stem cell research issued yesterday by the National Institutes of Health (NIH). The text of his statement follows:

"In April I criticized the NIH's draft guidelines for destructive embryonic stem cell research, saying that under these guidelines 'federal tax dollars will be used to encourage destruction of living embryonic human beings for stem cell research - including human beings who otherwise would have survived and been born.'

"The final guidelines issued yesterday are even broader. Parents who are asked to consider having their embryonic children destroyed for research will not even have to be informed about all their other options - only about the options that happen to be available at their particular fertility clinic. Moreover, under the final guidelines, stem cell lines that existed previously or that are produced in foreign countries may be made eligible for federally funded research even if they were obtained in ways that violate one or more of the NIH's own informed consent requirements.

"The comments of tens of thousands of Americans opposing the destruction of innocent human life for stem cell research were simply ignored in this process. Even comments filed by the Catholic bishops' conference and others against specific abuses in the draft guidelines were not addressed. For example, federally funded researchers will be allowed to insert human embryonic stem cells into the embryos of animal species other than primates; federal grants will be available even to researchers who themselves destroyed human embryos to obtain the stem cells for their research. Existing federal law against funding research in which human embryos are harmed or destroyed is not given due respect here.

"This debate now shifts to Congress, where some members have said even this policy does not go far enough in treating some human beings as objects to be created, manipulated and destroyed for others' use. I hope Americans concerned about this issue will write to their elected representatives, urging them not to codify or further expand this unethical policy."

For more information about the USCCB's "Oppose Destructive Stem Cell Research" campaign, visit www.usccb.org/stemcellcampaign. Cardinal Rigali's April 21 statement on the draft guidelines is at www.usccb.org/comm/archives/2009/09-087.shtml. The USCCB's official comment letter of May 22 is at www.usccb.org/prolife/NIHcomments.pdf.


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
(Date:3/28/2017)... ... 28, 2017 , ... The Radiology Business Management Association (RBMA) is ... its new executive director. Mr. Still was selected through a careful months-long search by ... he is known to our members, has been a part of building the RBMA ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group ... serving as new board chair for Orange County health care system CalOptima Friday. ... of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... STRASBOURG, France and TEL AVIV, Israel ... opening a subsidiary in Israel . This new ... , will be mostly dedicated to research and development of novel ... Emosis Ltd will also, when relevant, locally support commercialization and sales ... ...
(Date:3/28/2017)...  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical ... other unmet medical needs, announced today two poster ... annual meeting.  The first poster to be presented ... ENMD-2076 in Combination with Anti-PD1 in Syngeneic Cancer ... presented on April 4 is entitled " Kinase ...
(Date:3/28/2017)... The global flow cytometry ... by 2025, according to a new study by Grand ... and cancer is expected to upsurge the demand for ... coming years. In addition, higher number of physicians is ... cell therapy, due to adverse effects caused by chemotherapy ...
Breaking Medicine Technology: